Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:USA FDA Guidance for Industry - Electronic Source Data in Clinical Investigations Sep-2013 II: Difference between revisions

From GxPlex

Jump to: navigation, search
gxplex>GxPlexBot
Import from GxPlex Excel
 
gxplex>GxPlexBot
Import from GxPlex Excel
(No difference)

Revision as of 19:36, 27 June 2026


Document Information

Document information
Reference USA FDA Guidance for Industry -

Electronic Source Data in Clinical Investigations Sep-2013

Validity area USA
Scope(s) G
Document name FDA Guidance for Industry -

Electronic Source Data in Clinical Investigations

Version / Revision Sep-2013
Status Current
Document type Official recommendation
Language(s) EN
Description Guidance for Industry Electronic Source Data in Clinical Investigations
Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details

Scope G
Document part II
Language EN
Original entry by Florian Adragna
Contributors
Tags (EN)
Tags (original language)
Tags (FR)
Comment ALCOA principles for source data (FDA)

Text

[…] Source data should be attributable, legible, contemporaneous, original, and accurate (ALCOA) and must meet the regulatory requirements for recordkeeping. […]